Residency · Residency · Vascular Surgery
Graft Surveillance and Management of Bypass Graft Failure
Overview
Infrainguinal bypass grafts require ongoing surveillance to detect stenoses before graft thrombosis occurs. The primary goal of this surveillance is to identify and correct "failing grafts," which are hemodynamically significant stenoses that threaten graft patency. When a graft thromboses, it has far worse secondary patency and limb salvage outcomes compared to a graft that is revised before thrombosis. Duplex ultrasound surveillance is the standard of care for monitoring these grafts. It is important to recognize that different failure mechanisms predominate at different time intervals after surgery.
Mechanisms of Graft Failure by Time Period
Early Failure (<30 days)
In the first 30 days after surgery, technical errors are the most common cause of graft failure. These errors include anastomotic stenosis due to suture technique or an intimal flap, retained valve leaflets or unrecognized arteriovenous (AV) fistulae in in-situ bypasses, graft kinking or twisting, clamp injury to the native artery, and inadequate inflow or poor outflow vessel selection. Thrombosis can result from any of these issues or from a hypercoagulable state. Additionally, perioperative hypotension or low flow states contribute to early failure. Prevention relies on meticulous surgical technique and mandatory completion imaging to confirm graft integrity.
Intermediate Failure (1-24 months)
Between one month and two years postoperatively, intimal hyperplasia is the dominant mechanism of graft failure. This process involves smooth muscle cell proliferation and matrix deposition, typically occurring at the proximal and distal anastomoses—with the distal anastomosis being the most common site—as well as at valve sites in vein grafts and areas of prior vein injury such as clamp sites or branch ligation points. Intimal hyperplasia develops progressively and can be detected on surveillance before thrombosis occurs. Late recognition of retained valves or AV fistulae in in-situ bypass grafts may also contribute to failure during this period.
Late Failure (>24 months)
After two years, graft failure is most commonly due to progression of atherosclerotic disease in the inflow or outflow arteries, atherosclerotic degeneration of the vein graft itself, anastomotic pseudoaneurysm formation, or graft infection, which can present late.
| Time Period | Interval | Predominant Mechanism | Common Causes | Prevention/Detection |
|---|---|---|---|---|
| Early | <30 days | Technical error | Anastomotic stenosis, retained valve, kinking, clamp injury, poor outflow | Completion imaging; meticulous technique |
| Intermediate | 1–24 months | Intimal hyperplasia | Distal anastomosis, valve sites, clamp sites, branch ligation points | Duplex surveillance every 3–6 months |
| Late | >24 months | Disease progression | Inflow/outflow atherosclerosis, graft degeneration, pseudoaneurysm, infection | Annual duplex; ABI monitoring |
<image>Timeline diagram showing the predominant mechanisms of infrainguinal bypass graft failure across early (less than 30 days), intermediate (1-24 months), and late (greater than 24 months) periods, with illustrations of technical error, intimal hyperplasia, and atherosclerotic progression</image>
Duplex Ultrasound Surveillance
Rationale
Randomized trials and large observational studies have demonstrated that surveillance improves assisted primary patency and limb salvage. Identifying a "failing graft" with stenosis allows for elective revision rather than emergent thrombectomy. Repairing a failing graft results in secondary patency rates exceeding 80%, whereas repairing a thrombosed graft yields secondary patency rates of only 50-60%.
Protocol
Surveillance typically begins with a baseline duplex ultrasound within 30 days of surgery to identify technical problems. Follow-up scans are performed at 3 months to detect early intimal hyperplasia and at 6 months, which is the peak period for intimal hyperplasia development. Subsequently, duplex ultrasound is repeated every 6 months for the first two years and annually thereafter if the graft remains stable. Additional scans are indicated if there is a clinical change such as new symptoms, changes in pulses, or a drop in ankle-brachial index (ABI).
Duplex Ultrasound Criteria for Graft Stenosis
Several parameters guide the interpretation of duplex ultrasound findings. A peak systolic velocity (PSV) greater than 300 cm/s indicates significant stenosis, corresponding to more than 70% diameter reduction. A PSV ratio (velocity ratio, Vr) exceeding 3.5 at a focal point also suggests stenosis. A mid-graft PSV less than 45 cm/s indicates a low-flow state and impending graft failure. A decrease in ABI greater than 0.15 from baseline signifies a hemodynamically significant change. An increase in end-diastolic velocity suggests a high-grade stenosis.
What to Scan
The entire graft should be scanned from the proximal to the distal anastomosis, including the inflow artery (at least the common femoral artery), the outflow artery distal to the anastomosis, both anastomoses (which are the most common sites of stenosis), valve sites in in-situ grafts, branch ligation sites, and any area showing abnormal wall thickening or changes in vessel caliber.
Indications for Graft Revision
Graft revision is indicated when the PSV exceeds 300 cm/s or the PSV ratio is greater than 3.5 at any point within the graft. A mid-graft velocity below 45 cm/s, progressive velocity increases on serial studies, an ABI decline greater than 0.15 from baseline, or clinical deterioration such as return of symptoms also warrant consideration for revision. It is crucial to interpret these findings in the context of trends over time rather than relying on a single measurement.
Management of the Failing Graft (Stenosis Detected)
Open Surgical Revision
Open surgical revision options include patch angioplasty for focal stenosis at the anastomosis or valve site, typically using a vein patch which is preferred over prosthetic material. Interposition grafting involves excising the stenotic segment and replacing it with a vein graft. A jump graft bypasses the stenotic segment with a new vein conduit. Endarterectomy is reserved for inflow lesions such as those involving the common femoral artery.
Endovascular Options
Percutaneous transluminal angioplasty (PTA) is useful for focal, short stenoses, especially within the graft body. While PTA offers acceptable short-term results, repeat procedures may be necessary. Cutting or scoring balloons may improve outcomes for resistant lesions. Stenting is generally avoided within vein grafts due to poor outcomes but may be considered for inflow lesions. Drug-coated balloons have an emerging role in treating vein graft stenosis, although data remain limited.
Choosing Between Open and Endovascular Revision
Open revision is generally preferred for anastomotic stenoses, particularly distal ones, long or multiple stenoses, and graft angulation or kinking. Endovascular approaches are favored for short, focal mid-graft stenoses, inflow lesions, and in patients with high surgical risk.
<image>Duplex ultrasound images of a vein graft showing normal mid-graft flow velocity waveform compared to a high-velocity jet at a stenotic segment with PSV greater than 300 cm/s and a velocity ratio greater than 3.5, with corresponding B-mode image of wall thickening</image>
Management of the Failed (Thrombosed) Graft
Immediate Assessment
When a graft thromboses, immediate assessment of limb viability using the Rutherford acute limb ischemia (ALI) classification is essential. Systemic heparin anticoagulation should be initiated promptly. Determining the timing and likely mechanism of thrombosis guides further management.
Surgical Thrombectomy and Revision
Fogarty catheter thrombectomy is performed to remove the thrombus from the graft. It is critical to identify and correct the underlying cause of thrombosis, often through completion angiography to detect stenotic lesions. Simultaneous revision of the causative lesion is necessary. If the graft is severely damaged or inadequate, a new bypass with an alternative conduit may be required.
Thrombolysis
Catheter-directed thrombolysis can restore graft patency and reveal the causative stenosis, especially when the cause is unclear. This approach allows identification and treatment of the underlying lesion after clot dissolution. However, the bleeding risk associated with thrombolysis must be carefully weighed.
Secondary Graft Patency
Thrombosed vein grafts have a secondary patency rate of 50-60% at one year following thrombectomy and revision, which is significantly worse than the 80-90% assisted primary patency achieved with pre-emptive revision of failing grafts. Repeated thrombosis may necessitate a new bypass or alternative revascularization strategy.
Prosthetic Graft Considerations
Prosthetic grafts, such as those made from polytetrafluoroethylene (PTFE), have higher failure rates than vein grafts. Although surveillance is still performed, many programs rely on clinical examination and ABI monitoring rather than routine duplex ultrasound. The primary failure mechanism is intimal hyperplasia at the distal anastomosis, especially in below-knee grafts. Some evidence suggests that anticoagulation with warfarin improves prosthetic graft patency below the knee. Thrombectomy is less successful in thrombosed prosthetic grafts compared to vein grafts.
Clinical Pearls
A graft surveillance program represents a commitment made at the time of surgery, and patients should be educated about the importance of follow-up. Duplex ultrasound surveillance is a technically demanding study, and its quality depends heavily on the skill of the vascular technologist. A low mid-graft velocity below 45 cm/s is an ominous sign even in the absence of a focal stenosis, indicating global low flow and impending thrombosis. It is essential to compare current studies to baseline and prior examinations, as trends over time are more informative than isolated values. Early graft failure within 30 days is usually due to technical problems, so reviewing the operative note and completion imaging is critical. Vein graft stenoses should never be treated primarily with stenting; open revision remains the preferred approach. For prosthetic grafts, routine ABI monitoring may serve as a simpler alternative to duplex surveillance.
<image>Intraoperative photograph of an open surgical revision of a vein graft stenosis at the distal anastomosis showing patch angioplasty with autogenous vein, demonstrating the exposed graft, arteriotomy, and the sutured vein patch</image>
References
- Bandyk DF. Surveillance after lower extremity arterial bypass. Perspect Vasc Surg Endovasc Ther. 2007;19(4):376-383.
- Conte MS, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure. J Vasc Surg. 2006;43(4):742-751.
- Lundell A, et al. Femoropopliteal-crural graft patency is improved by an intensive surveillance program. J Vasc Surg. 1995;21(1):26-33.
- Mills JL, et al. Vein graft surveillance: aggressive approach is justified. J Vasc Surg. 2003;37(1):10-15.
- Davies AH, et al. Vein graft surveillance improves patency in femoro-popliteal bypass. Eur J Vasc Endovasc Surg. 1995;9(4):402-408.
